Nasal high flow (NHF) is a mode of noninvasive respiratory support that delivers high flows of blended air and oxygen through a nasal interface.1
There is increasing evidence supporting the use of NHF in neonates, infants, and children. NHF typically improves therapy success and decreases the need for escalation of care when used early and cohesively across the hospital compared to standard oxygen therapy.2
There are several mechanisms of action and benefits associated with NHF therapy for neonates, infants, and children.
The delivery of dynamic positive airway pressure associated with NHF has been shown to reduce inspiratory effort and work of breathing compared to standard oxygen therapy.4-6
NHF is gentle on the nose, which improves patient comfort, compliance, and tolerance to therapy.7,8
There is a well-established evidence base that describes how NHF can be used to support the patient pathway through the hospital.
Learn more about the applications of NHF for different patient populations.